Limbo
New York
About Limbo
Limbo provides wearable technology that was created for diabetes management. These continuous glucose monitors (CGMs) transmit near real-time glucose data, providing instant feedback (via a companion mobile app) on how the body metabolizes different foods or responds to lifestyle decisions around exercise and sleep.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.7M
- Last round: Series Unknown (May 2024)
- Website: limborevolution.com
Industries & Categories
Apps, Artificial Intelligence (AI), Consumer Electronics, Health Care, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/limbo-40087 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.